NatureCeuticals
NatureCeuticals is a Malaysia-based biotechnology company that leads 3 cancer trials in OnCo, testing the botanical medicine Nuvastatic for cancer-related fatigue in colorectal cancer and triple-negative breast cancer.
Overview
NatureCeuticals is a Malaysian clinical-stage company developing standardised botanical medicines for supportive and adjunctive cancer care. Its lead product Nuvastatic, based on Orthosiphon stamineus leaf extract, is in phase 3 trials for cancer-related fatigue in patients receiving chemotherapy for colorectal and triple-negative breast cancer. On ClinicalTrials.gov it is the lead sponsor of 3 trials recorded in OnCo (3 in phase 3 or 2/3): NCT07669454 (phase 3, A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III...), NCT07669519 (phase 3, Evaluation of NuvastaticTM in Reducing Cancer-Related Fatigue in Colon Cancer Patients...) and NCT07669467 (phase 3, Nuvastatic® Phase III Trial for Fatigue in Triple-Negative Breast Cancer). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.